A detailed history of Ahrens Investment Partners LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Ahrens Investment Partners LLC holds 676 shares of ABT stock, worth $93,091. This represents 0.03% of its overall portfolio holdings.

Number of Shares
676
Holding current value
$93,091
% of portfolio
0.03%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 21, 2023

BUY
$96.86 - $114.01 $65,477 - $77,070
676 New
676 $68,000
Q2 2022

Aug 02, 2022

SELL
$102.07 - $123.37 $46,441 - $56,133
-455 Reduced 40.23%
676 $73,000
Q1 2022

Apr 28, 2022

BUY
$114.02 - $139.04 $56,667 - $69,102
497 Added 78.39%
1,131 $134,000
Q4 2021

Jan 21, 2022

BUY
$115.53 - $141.46 $73,246 - $89,685
634 New
634 $89,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $241B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Ahrens Investment Partners LLC Portfolio

Follow Ahrens Investment Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ahrens Investment Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ahrens Investment Partners LLC with notifications on news.